Correlation Between Affimed NV and ADMA Biologics

Can any of the company-specific risk be diversified away by investing in both Affimed NV and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Affimed NV and ADMA Biologics, you can compare the effects of market volatilities on Affimed NV and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and ADMA Biologics.

Diversification Opportunities for Affimed NV and ADMA Biologics

-0.12

Correlation Coefficient

Affimed NV  ADMA Biologics

Good diversification

The 3 months correlation between Affimed and ADMA is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Affimed NV i.e., Affimed NV and ADMA Biologics go up and down completely randomly.

Pair Corralation between Affimed NV and ADMA Biologics

Given the investment horizon of 90 days Affimed NV is expected to under-perform the ADMA Biologics. In addition to that, Affimed NV is 1.57 times more volatile than ADMA Biologics. It trades about -0.01 of its total potential returns per unit of risk. ADMA Biologics is currently generating about 0.17 per unit of volatility. If you would invest  414.00  in ADMA Biologics on September 13, 2024 and sell it today you would earn a total of  1,549  from holding ADMA Biologics or generate 374.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Affimed NV  vs.  ADMA Biologics

Affimed NV

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

ADMA Biologics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ADMA Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, ADMA Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Affimed NV and ADMA Biologics

The main advantage of trading using opposite Affimed NV and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.

The idea behind Affimed NV and ADMA Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.